329 related articles for article (PubMed ID: 30545330)
1. The incidence, risk factors and outcomes of early bloodstream infection in patients with malignant hematologic disease after unrelated cord blood transplantation: a retrospective study.
Ge J; Yang T; Zhang L; Zhang X; Zhu X; Tang B; Wan X; Tong J; Song K; Yao W; Sun G; Sun Z; Liu H
BMC Infect Dis; 2018 Dec; 18(1):654. PubMed ID: 30545330
[TBL] [Abstract][Full Text] [Related]
2. Bloodstream infections in adult patients undergoing cord blood transplantation from unrelated donors after myeloablative conditioning regimen.
Sanz J; Cano I; González-Barberá EM; Arango M; Reyes J; Montesinos P; Lorenzo I; Jarque I; Martínez J; López F; Arilla MJ; Lancharro A; Moscardó F; López-Hontangas JL; Salavert M; Sanz MA; Sanz GF
Biol Blood Marrow Transplant; 2015 Apr; 21(4):755-60. PubMed ID: 25585274
[TBL] [Abstract][Full Text] [Related]
3. Comparable long-term outcome of unrelated cord blood transplantation with related bone marrow or peripheral blood stem cell transplantation in patients aged 45 years or older with hematologic malignancies after myeloablative conditioning.
Konuma T; Kato S; Ooi J; Oiwa-Monna M; Kawamata T; Tojo A; Takahashi S
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1150-5. PubMed ID: 24727335
[TBL] [Abstract][Full Text] [Related]
4. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
[TBL] [Abstract][Full Text] [Related]
5. Pre-engraftment bloodstream infections in acute leukemia patients undergoing unrelated cord blood transplantation following intensified myeloablative conditioning without ATG.
Zheng C; Tang B; Zhu X; Zhang X; Zhang L; Geng L; Liu H; Sun Z
Ann Hematol; 2017 Jan; 96(1):115-124. PubMed ID: 27771742
[TBL] [Abstract][Full Text] [Related]
6. Comparative outcomes between cord blood transplantation and bone marrow or peripheral blood stem cell transplantation from unrelated donors in patients with hematologic malignancies: a single-institute analysis.
Chen YH; Xu LP; Liu DH; Chen H; Zhang XH; Han W; Wang FR; Wang JZ; Wang Y; Huang XJ; Liu KY
Chin Med J (Engl); 2013 Jul; 126(13):2499-503. PubMed ID: 23823825
[TBL] [Abstract][Full Text] [Related]
7. Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor.
Mikulska M; Raiola AM; Galaverna F; Balletto E; Borghesi ML; Varaldo R; Gualandi F; Giannoni L; Pastori G; Giacobbe DR; Signori A; Del Bono V; Viscoli C; Bacigalupo A; Angelucci E
Biol Blood Marrow Transplant; 2018 Jan; 24(1):109-118. PubMed ID: 28860000
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of bloodstream infections after myeloablative and non-myeloablative allogeneic hematopoietic stem cell transplantation: A single-center cohort study.
Gjaerde LI; Moser C; Sengeløv H
Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28561378
[TBL] [Abstract][Full Text] [Related]
9. Bacterial bloodstream infection in neutropenic adult patients after myeloablative cord blood transplantation: experience of a single institution in Japan.
Tomonari A; Takahashi S; Ooi J; Tsukada N; Konuma T; Kobayashi T; Sato A; Takasugi K; Iseki T; Tojo A; Asano S
Int J Hematol; 2007 Apr; 85(3):238-41. PubMed ID: 17483061
[TBL] [Abstract][Full Text] [Related]
10. Comparison of stem cell sources in the severity of dry eye after allogeneic haematopoietic stem cell transplantation.
Uchino M; Ogawa Y; Uchino Y; Mori T; Okamoto S; Tsubota K
Br J Ophthalmol; 2012 Jan; 96(1):34-7. PubMed ID: 22053104
[TBL] [Abstract][Full Text] [Related]
11. Comparative single-institute analysis of cord blood transplantation from unrelated donors with bone marrow or peripheral blood stem-cell transplants from related donors in adult patients with hematologic malignancies after myeloablative conditioning regimen.
Takahashi S; Ooi J; Tomonari A; Konuma T; Tsukada N; Oiwa-Monna M; Fukuno K; Uchiyama M; Takasugi K; Iseki T; Tojo A; Yamaguchi T; Asano S
Blood; 2007 Feb; 109(3):1322-30. PubMed ID: 17038536
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation.
Kikuchi M; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Sakamoto K; Kawamura K; Ishihara Y; Sato M; Ashizawa M; Terasako-Saito K; Kimura S; Yamazaki R; Kanda J; Kako S; Nishida J; Kanda Y
Transpl Infect Dis; 2015 Feb; 17(1):56-65. PubMed ID: 25580541
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Resistant Gram-Negative Bacilli in Bloodstream Infection in Febrile Neutropenia Patients Undergoing Hematopoietic Stem Cell Transplantation: A Single Center Retrospective Cohort Study.
Wang L; Wang Y; Fan X; Tang W; Hu J
Medicine (Baltimore); 2015 Nov; 94(45):e1931. PubMed ID: 26559260
[TBL] [Abstract][Full Text] [Related]
14. [Risk factors and treatment of hemorrhagic cystitis in children after hematopoietic stem cell transplantation].
Xu HG; Fang JP; Huang SL; Zhou DH; Chen C; Huang K; Li Y
Zhonghua Er Ke Za Zhi; 2006 Feb; 44(2):126-30. PubMed ID: 16624030
[TBL] [Abstract][Full Text] [Related]
15. Low Counts of Plasmacytoid Dendritic Cells after Engraftment Are Associated with High Early Mortality after Allogeneic Stem Cell Transplantation.
Gonçalves MV; Yamamoto M; Kimura EY; Colturato VA; de Souza MP; Mauad M; Ikoma MV; Novis Y; Rocha V; Ginani VC; Wanderley de Oliveira Felix OM; Seber A; Kerbauy FR; Hamerschlak N; Orfao A; Rodrigues CA
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1223-9. PubMed ID: 25792371
[TBL] [Abstract][Full Text] [Related]
16. Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury-Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant.
Dandoy CE; Kim S; Chen M; Ahn KW; Ardura MI; Brown V; Chhabra S; Diaz MA; Dvorak C; Farhadfar N; Flagg A; Ganguly S; Hale GA; Hashmi SK; Hematti P; Martino R; Nishihori T; Nusrat R; Olsson RF; Rotz SJ; Sung AD; Perales MA; Lindemans CA; Komanduri KV; Riches ML
JAMA Netw Open; 2020 Jan; 3(1):e1918668. PubMed ID: 31913492
[TBL] [Abstract][Full Text] [Related]
17. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology, risk factors and outcomes of multi-drug-resistant bloodstream infections in haematopoietic stem cell transplant recipients: importance of previous gut colonization.
Ferreira AM; Moreira F; Guimaraes T; Spadão F; Ramos JF; Batista MV; Filho JS; Costa SF; Rocha V
J Hosp Infect; 2018 Sep; 100(1):83-91. PubMed ID: 29530743
[TBL] [Abstract][Full Text] [Related]
19. Comparison of transplant outcomes from matched sibling bone marrow or peripheral blood stem cell and unrelated cord blood in patients 50 years or older.
Konuma T; Tsukada N; Kanda J; Uchida N; Ohno Y; Miyakoshi S; Kanamori H; Hidaka M; Sakura T; Onizuka M; Kobayashi N; Sawa M; Eto T; Matsuhashi Y; Kato K; Ichinohe T; Atsuta Y; Miyamura K;
Am J Hematol; 2016 May; 91(5):E284-92. PubMed ID: 26910296
[TBL] [Abstract][Full Text] [Related]
20. Contribution of specific pathogens to bloodstream infection mortality in neutropenic patients with hematologic malignancies: Results from a multicentric surveillance cohort study.
Kern WV; Roth JA; Bertz H; Götting T; Dettenkofer M; Widmer AF; Theilacker C;
Transpl Infect Dis; 2019 Dec; 21(6):e13186. PubMed ID: 31574202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
